ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Novel Effect of miR-26a:Mdm2:p53 Pathway on Mouse Liver Regeneration.

    J. Zhou, W. Ju, X. Yuan, X. Jiao, D. Wang, X. Zhu, X. He.

    Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

    BACKGROUND: The deficiency of liver regeneration needs to be addressed in the fields of liver surgery, split liver transplantation and living donor liver transplantation. Researches…
  • 2016 American Transplant Congress

    A Novel, Non-Viral mRNA Delivery System for Targeted Protein Translation in Human Islets.

    J. Oberholzer,1,2 D. Gutierrez,1,2 E. Marchese,1 M. Nourmohammadzadeh,1,2 Y. Wang.1,2

    1Department of Surgery, University of Illinois at Chicago, Chicago, IL; 2Department of Bioengineering, University of Illinois at Chicago, Chicago, IL.

    Background: We propose using an innovative technology that utilizes gold nanoparticles (AuNPs) as a non-viral method of delivery. Our laboratory was one of the first…
  • 2016 American Transplant Congress

    NKG2A-Expressing Natural Killer Cells Dominate the Response to Latent Epstein-Barr Virus Infection.

    O. Hatton,1 D. Strauss-Albee,2 S. Krams,1 C. Blish,2 O. Martinez.1

    1Surgery, Stanford University School of Medicine, Stanford, CA; 2Medicine, Stanford Univerity School of Medicine, Stanford, CA.

    Introduction: EBV infection elicits a robust host immune response in healthy, immunocompetant individuals. EBV immunity is essential for preventing EBV­-associated lymphomas in transplant recipients, including…
  • 2016 American Transplant Congress

    Ex Vivo Expansion and Functional Characterization of Human Alloantigen-Specific Regulatory T Cells.

    J. Mathew,1 S. McEwen,1 I. Konieczna,1 X. Huang,1 J. He,1 R. Kornbluth,2 J. Miller,1 L. Gallon,1 J. Leventhal.1

    1Surgery - Comprehensive Transplant Center, Northwestern University, Chicago, IL; 2Multimeric Biotherapeutics, Inc, La Jolla, CA.

    Purpose: Regulatory T cells (Tregs) have been associated with clinical transplant tolerance and they have been shown to prolong graft survival in animal models without…
  • 2016 American Transplant Congress

    Vaccination Compliance in Listed Kidney Transplant Candidates: A Retrospective Chart Review.

    I. Tawhari,1 C. Staffeld-Coit,2 J. Garcia-Diaz.1

    1Infectious Disease, Ochsner Health System, New Orleans, LA; 2Nephrology, Ochsner Health System, New Orleans, LA.

    Background: Infections in solid organ transplant recipients, some of which are vaccine preventable, may result in excessive morbidity and mortality. Immunosuppressive agents increase the risk…
  • 2016 American Transplant Congress

    Innate Immune Signaling During Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation.

    R. Sosa,1 A. Zarrinpar,2 C. Lassman,1 R. Busuttil,2 D. Gjertson,1 J. Kupiec-Weglinski,1 E. Reed.1

    1Pathology and Lab Medicine, University of California-Los Angeles, Los Angeles, CA; 2Surgery, University of California-Los Angeles, Los Angeles, CA.

    Background: Orthotopic liver transplantation (OLT) success is hampered by cellular damage elicited by ischemia-reperfusion injury (IRI) which lowers allograft survival. Research using murine models has…
  • 2016 American Transplant Congress

    Successful Prophylactic Use of Eculizumab in aHUS Kidney Transplant Patients: A Report of 9 Cases.

    A. Kumar,1 Z. Stewart,3 A. Reed,3 D. Orozco,2 R. Smith,1,2 C. Nester,1,2 C. Thomas.1,2

    1Internal Medicine, Univ of Iowa, Iowa City; 2Pediatrics, Univ of Iowa, Iowa City; 3Surgery, Univ of Iowa, Iowa City.

    AHUS is a thrombotic microangiopathy (TMA) triggered by alternate complement pathway (AP) dysregulation. In 60% of patients, a pathogenic variant can be identified in one…
  • 2016 American Transplant Congress

    Should HLA DR and DQ Eplet Mismatching Replace Traditional DR and DQ Mismatching for Deceased Donor Offers in Pediatric Renal Transplantation?

    C. Bryan, V. Chadha, B. Warady.

    Midwest Transplant Network, Kansas City, KS; Nephrology, Childrens Mercy Hospital, Kansas City, MO; Nephrology, Childrens Mercy Hospital, Kansas City, MO.

    Introduction. It is now appreciated that greater HLA DR mismatching of the first pediatric kidney transplantation is associated with higher degrees of sensitization, lower rates…
  • 2016 American Transplant Congress

    Influence of Donor and Recipient CYP3A4, CYP3A5 and ABCB1 Genotypes on Outcomes in Liver Transplants.

    M. Debette-Gratien,1 J. Woillard,2 N. Picard,2 M. Sebbagh,4 D. Sautereau,5 V. Loustaud-Ratti,1 D. Samuel,3 P. Marquet.2

    1Hepatology, INSERM UMR 850, Univ Limoges, CHU Limoges, Limoges, France; 2Pharmacology and Toxicology, INSERM UMR 850, Univ Limoges, CHU Limoges, Limoges, France; 3Hepatology, INSERM U785, Centre hépatobiliaire, Villejuif, France; 4Hepatology, Centre Hépatobiliaire, Villejuif, France; 5Hepatology, CHU Limoges, Limoges, France.

    Liver transplantation is a life-saving technique for patients with end-stage liver disease. Pharmacogenetics is promising to explain a part of variability of calcineurin inhibitors efficacy…
  • 2016 American Transplant Congress

    Optimal Integration of Kidney Exchange Programs with Antibody Reduction Therapy to Increase Successful Transplant in Difficult to Match Recipients.

    K. Melancon,1 N. Koizumi,2 M. Gentili,3 C. Callender.4

    1Surgery, George Washington University Hospital, Washington, DC; 2Public Policy, George Mason Univ, Arlington, VA; 3Operations Research, University of Louisville, Louisville, KY; 4Surgery, Howard University Hospital, Washington, DC.

    Kidney paired donation (KPD) allows incompatible pairs to exchange kidneys with other incompatible pairs. However, evidence suggests there stills exist barriers to KPD utilization, especially…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences